Compound class:
Synthetic organic
Comment: Compound 12b is a novel conformationally restricted, potent mTOR inhibitor [1]. Although it is an ATP-competitive inhibitor, its novel chemical scaffold dictates it selectivity.
![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Bioactivity Comments |
Compound 12b exhibits ∼450-fold selectivity for mTOR over class I PI3K isoforms [1]. It is orally active, metabolically stable and displays minimum brain penetration (this latter attribute indicates a bias for treating systemic tumours). |
Selectivity at enzymes | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|